SBIR/STTR Research Award

Commercial Prototype of Optoacoustic Breast Imager

Award identifier b547e49225f8949c36aae0a851b9b9980345906481e6ded0862635987725307aAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$830,333

Program and phase

SBIR · Phase II

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
FAIRWAY MEDICAL TECHNOLOGIES, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant):Experimental work done to date indicates that Optoacoustic Tomography will provide breast images with greater contrast and sensitivity to cancer than the currently preferred methods. In a Laser Optoacoustic Imaging System (LOIS), short, near-infrared laser pulses are preferentially absorbed by breast tumors. As a result, pressure waves are generated at the absorption sites. These propagate to the surface where they can be detected with ultra-wideband ultrasonic transducers. Computer processing of the detected signals results in an image in which contrast is largely determined by the tissue blood content. Cancerous tumors are blood rich because they develop a dense network of leaky blood vessels through the process of angiogenesis. The contrast in an optoacoustic image is significantly higher than that in images acquired with x-rays or ultrasound. Imaging with 2 different laser wavelengths can provide diagnostic information. Images taken with a wavelength of 1064 nm are particularly sensitive to the distribution of oxygenated blood. Images taken with a wavelength of 760 nm are more sensitive to the distribution of deoxygenated blood. Combining and/or comparing the two types of images yields a means for differentiation between cancerous and non-cancerous lesion. LOIS is suitable for examination of the breasts of all women, regardless of their age or skin color. The overall goal of this project is to develop a commercial prototype optoacoustic imager. The work of the Lasersonix team during Phase II will focus on incorporation of the components developed in Phase I into a complete 2D imaging system called LOIS-2D. LOIS-2D will be tested with 24 patients with suspicious breast lesions to verify the proper performance of the equipment and to perform initial tests of its diagnostic capability in collaboration with UTMB. The commercial prototype of a 3D optoacoustic imager, LOIS-3D, will be designed, developed, and fabricated. Specifically, a three-dimensional transducer array will be produced. The electronics and software will be modified to handle an increased number of detectors. The number of electronic channels that can be processed in parallel will be increased to 128. Image reconstruction will be performed in hardware. 3D images will be reconstructed in close to real time through a computer fusion of 20 images produced in real time.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.